FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123161505> ?p ?o ?g. }

• W2123161505 endingPage "1276" @default.
• W2123161505 startingPage "1271" @default.
• W2123161505 abstract "Limited literature exists regarding the safety of testosterone therapy in men treated for prostate cancer. We present multi-institutional data on testosterone therapy in hypogonadal men with prostate cancer treated with radiation therapy.We retrospectively reviewed the records of hypogonadal men treated with testosterone therapy after radiation therapy for prostate cancer at 4 institutions. Serum testosterone, free testosterone, estradiol, sex hormone-binding globulin, prostate specific antigen, prostate specific antigen velocity and prostate biopsy findings were analyzed.A total of 98 men were treated with radiation therapy. Median age was 70.0 years (range 63.0 to 74.3) at initiation of testosterone therapy. Median baseline testosterone was 209 ng/dl (range 152 to 263) and median baseline prostate specific antigen was 0.08 ng/ml (range 0.00 to 0.33). In the cohort the tumor Gleason score was 5 in 3 men (3.1%), 6 in 44 (44.9%), 7 in 28 (28.6%), 8 in 7 (7.1%) and 9 in 4 (4.1%). Median followup was 40.8 months (range 1.5 to 147). Serum testosterone increased to a median of 420 ng/dl (range 231 to 711) during followup (p <0.001). Overall a nonsignificant increase in mean prostate specific antigen was observed from 0.08 ng/ml at baseline to 0.09 ng/ml (p = 0.05). Among patients at high risk prostate specific antigen increased from 0.10 to 0.36 ng/ml (p = 0.018). Six men (6.1%) met criteria for biochemical recurrence.Testosterone therapy in men following radiation therapy for prostate cancer was associated with a minor increase in serum prostate specific antigen and a low rate of biochemical recurrence." @default.
• W2123161505 created "2016-06-24" @default.
• W2123161505 creator A5010030105 @default.
• W2123161505 creator A5024599210 @default.
• W2123161505 creator A5028172869 @default.
• W2123161505 creator A5036455420 @default.
• W2123161505 creator A5038093352 @default.
• W2123161505 creator A5053480742 @default.
• W2123161505 creator A5059348210 @default.
• W2123161505 creator A5065656557 @default.
• W2123161505 creator A5069888995 @default.
• W2123161505 creator A5076495870 @default.
• W2123161505 creator A5087500960 @default.
• W2123161505 date "2015-11-01" @default.
• W2123161505 modified "2023-09-24" @default.
• W2123161505 title "Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer" @default.
• W2123161505 cites W1581939760 @default.
• W2123161505 cites W1905464153 @default.
• W2123161505 cites W1972738089 @default.
• W2123161505 cites W1994769526 @default.
• W2123161505 cites W1995484476 @default.
• W2123161505 cites W1998654117 @default.
• W2123161505 cites W2009351118 @default.
• W2123161505 cites W2013481831 @default.
• W2123161505 cites W2013559131 @default.
• W2123161505 cites W2021070586 @default.
• W2123161505 cites W2033694952 @default.
• W2123161505 cites W2035711444 @default.
• W2123161505 cites W2041666797 @default.
• W2123161505 cites W2049153532 @default.
• W2123161505 cites W2067736786 @default.
• W2123161505 cites W2089403922 @default.
• W2123161505 cites W2091445581 @default.
• W2123161505 cites W2095618848 @default.
• W2123161505 cites W2113645951 @default.
• W2123161505 cites W2116966996 @default.
• W2123161505 cites W2119776733 @default.
• W2123161505 cites W2121614322 @default.
• W2123161505 cites W2135798327 @default.
• W2123161505 cites W2140626582 @default.
• W2123161505 cites W2151484054 @default.
• W2123161505 cites W2160302718 @default.
• W2123161505 cites W2161749968 @default.
• W2123161505 doi "https://doi.org/10.1016/j.juro.2015.05.084" @default.
• W2123161505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26025500" @default.
• W2123161505 hasPublicationYear "2015" @default.
• W2123161505 type Work @default.
• W2123161505 sameAs 2123161505 @default.
• W2123161505 citedByCount "39" @default.
• W2123161505 countsByYear W21231615052015 @default.
• W2123161505 countsByYear W21231615052016 @default.
• W2123161505 countsByYear W21231615052017 @default.
• W2123161505 countsByYear W21231615052018 @default.
• W2123161505 countsByYear W21231615052019 @default.
• W2123161505 countsByYear W21231615052020 @default.
• W2123161505 countsByYear W21231615052021 @default.
• W2123161505 countsByYear W21231615052022 @default.
• W2123161505 countsByYear W21231615052023 @default.
• W2123161505 crossrefType "journal-article" @default.
• W2123161505 hasAuthorship W2123161505A5010030105 @default.
• W2123161505 hasAuthorship W2123161505A5024599210 @default.
• W2123161505 hasAuthorship W2123161505A5028172869 @default.
• W2123161505 hasAuthorship W2123161505A5036455420 @default.
• W2123161505 hasAuthorship W2123161505A5038093352 @default.
• W2123161505 hasAuthorship W2123161505A5053480742 @default.
• W2123161505 hasAuthorship W2123161505A5059348210 @default.
• W2123161505 hasAuthorship W2123161505A5065656557 @default.
• W2123161505 hasAuthorship W2123161505A5069888995 @default.
• W2123161505 hasAuthorship W2123161505A5076495870 @default.
• W2123161505 hasAuthorship W2123161505A5087500960 @default.
• W2123161505 hasConcept C121608353 @default.
• W2123161505 hasConcept C126322002 @default.
• W2123161505 hasConcept C126894567 @default.
• W2123161505 hasConcept C143998085 @default.
• W2123161505 hasConcept C2776235491 @default.
• W2123161505 hasConcept C2779279991 @default.
• W2123161505 hasConcept C2780192828 @default.
• W2123161505 hasConcept C2780275930 @default.
• W2123161505 hasConcept C2781406297 @default.
• W2123161505 hasConcept C29456083 @default.
• W2123161505 hasConcept C509974204 @default.
• W2123161505 hasConcept C530470458 @default.
• W2123161505 hasConcept C71924100 @default.
• W2123161505 hasConceptScore W2123161505C121608353 @default.
• W2123161505 hasConceptScore W2123161505C126322002 @default.
• W2123161505 hasConceptScore W2123161505C126894567 @default.
• W2123161505 hasConceptScore W2123161505C143998085 @default.
• W2123161505 hasConceptScore W2123161505C2776235491 @default.
• W2123161505 hasConceptScore W2123161505C2779279991 @default.
• W2123161505 hasConceptScore W2123161505C2780192828 @default.
• W2123161505 hasConceptScore W2123161505C2780275930 @default.
• W2123161505 hasConceptScore W2123161505C2781406297 @default.
• W2123161505 hasConceptScore W2123161505C29456083 @default.
• W2123161505 hasConceptScore W2123161505C509974204 @default.
• W2123161505 hasConceptScore W2123161505C530470458 @default.
• W2123161505 hasConceptScore W2123161505C71924100 @default.
• W2123161505 hasIssue "5" @default.
• W2123161505 hasLocation W21231615051 @default.

• next